Herbal compositions for the prevention or treatment of benign prostatic hyperplasia and related disorders
AssigneeSeipel Group Pty Ltd
InventorTracey Anne Seipel
Life of this patent
Estimating the term…
Abstract
Provided in one embodiment is an herbal composition for the prevention or treatment of disorders of the prostate, for example, benign prostatic hyperplasia (BPH), prostatitis, and prostatic intraepithelial neoplasia, and for overactive bladder (OAB), urinary incontinence (UI), nocturia, poor urinary stream, and straining to urinate associated with these prostate disorders. Specifically one embodiment provides compositions that contain Crateva nurvala, Equisetum arvense, Lindera aggregata, and Serenoa repens, and methods of use thereof.
Claims20
An herb-containing composition, comprising:
- (i) a Crateva nurvala extract preparation;
- (ii) an Equisetum arvense extract preparation;
- (iii) a Lindera aggregata extract preparation;
- and
- (iv) a Serenoa repens extract preparation, wherein the herb-containing composition is formulated as an oral dosage unit.
An herb-containing composition, comprising:
- (i) a Crateva nurvala stem/bark extract preparation present;
- (ii) an Equisetum arvense stem extract preparation;
- (iii) a Lindera aggregata root extract preparation;
- and
- (iv) a Serenoa repens leave/berry extract preparation,
- wherein the herb-containing composition is formulated as an oral dosage unit, and wherein the Equisetum arvense stem extract preparation and the Lindera aggregata root extract preparation are present at the same concentration.
A method for the prevention or treatment of the symptoms of Benign Prostate Hypertrophy (BPH), comprising:
- administering an herb-containing composition to a subject in need thereof, wherein the herb-containing composition comprises:
- (i) a Crateva nurvala extract preparation;
- (ii) an Equisetum arvense extract preparation;
- (iii) a Lindera aggregata extract preparation;
- and
- (iv) a Serenoa repens extract preparation, and wherein the herb-containing composition is formulated as an oral dosage unit.
Dependencies are inferred from the claim text.